VEE as Bioweapon
•
FDR authorized development of VEE as a
biological warfare agent with offensive and
defensive objectives
–
Incapacitating agent
–
Led to development of attenuated TC‐83 vaccine
strain and inactivated C 84 vaccine strain
‐
–
Aerosol, solid, liquid forms possible
•
R. Nixon cancelled biological weapons program
•
Other countries were/are suspected of VEE as BT
VEEV – Existing PCR assays
•
Purpose: Detect VEEV RNA in
clinical samples from horses
–
Brain is preferred sample
–
Horse is an amplifying host
•
Target: E2 membrane glycoprotein
–
Associated with virus attachment to cells
–
Antibody to E2 neutralizes VEEV
–
Subtype differentiation by primer
selection and sequencing of amplicon
•
Nested PCR method
–
Enhances sensitivity
–
Cross contamination risks
